2,5-dimethoxy-4-chlorophenethylamine
Structural formula | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General | |||||||||||||
Surname | 2,5-dimethoxy-4-chlorophenethylamine | ||||||||||||
other names |
|
||||||||||||
Molecular formula | C 10 H 14 ClNO 2 | ||||||||||||
Brief description |
white crystals (hydrochloride) |
||||||||||||
External identifiers / databases | |||||||||||||
|
|||||||||||||
properties | |||||||||||||
Molar mass | 215.68 g mol −1 | ||||||||||||
Physical state |
firmly |
||||||||||||
Melting point |
220–221 ° C (hydrochloride) |
||||||||||||
safety instructions | |||||||||||||
|
|||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
2,5-Dimethoxy-4-chlorophenethylamine (abbreviated 2C-C ) is a psychedelically effective hallucinogen , which, due to its structure, belongs to the substance groups of phenol ethers , phenethylamines , as well as to the substance group of 2Cs .
history
The American chemist Alexander Shulgin synthesized 2C-C for the first time and mentions synthesis, effect and dose in his book PiHKAL .
synthesis
Several synthetic routes are known. Two possible ones are described in PiHKAL.
Pharmacodynamics
2C-C acts (among other things) as a serotonin-noradrenaline reuptake inhibitor (IC 50 5-HT: 31 ± 7.8 μM NE: 63 ± 18 μM). Its effects are described as hallucinogenic .
Pharmacokinetics
Shulgin indicates the orally effective dose in the range of 20 to 40 mg, the duration of action is four to eight hours.
Legal status
2C-C was not subject to the Narcotics Act in Germany until 2014 , but has been prohibited since the twenty-eighth ordinance amending the narcotics law on December 5, 2014 ( Federal Law Gazette I, p. 1999 ).
literature
- Alexander Shulgin, Ann Shulgin: PIHKAL - A Chemical Love Story Transform Press, ISBN 0-9630096-0-5 .
Web links
Individual evidence
- ↑ a b c d e PiHKAL # 22 2C-C
- ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
- ↑ F. Nagai, R. Nonaka, K. Satoh Hisashi Kamimura: The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. In: European journal of pharmacology. Volume 559, Number 2-3, March 2007, pp. 132-137, doi : 10.1016 / j.ejphar.2006.11.075 . PMID 17223101 .